Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 311-330, June 2006

Treatment of PCOS in adolescence

  • Julia Warren-Ulanch, MD (Adult and Pediatric Endocrinology Fellow, University of Pittsburgh Medical Center)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1 412 692 7466; fax: +1 412 692 5834.
  • Silva Arslanian, MD (Professor of Pediatrics, University of Pittsburgh School of Medicine; Director, Weight Management and Wellness Center; and Director, General Clinical Research Center)

Division of Endocrinology, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213-2583, USA

Polycystic ovary syndrome (PCOS) is increasingly being recognized in adolescent girls seeking treatment for signs and symptoms of hyperandrogenism. It is difficult to diagnose PCOS in adolescents, therefore a high index of suspicion is necessary. Timely screening and treatment are crucial because another important component of the syndrome is insulin resistance/hyperinsulinemia increasing the risk for type 2 diabetes, dyslipidemia, and cardiovascular sequelae. Diagnosis of PCOS in adolescents should include a thorough family history, exclusion of other causes of hyperandrogenism, and appropriate laboratory evaluation. The scarcity of controlled clinical trials makes treatment controversial. Therapeutic options include lifestyle intervention, oral contraceptive pills, and insulin sensitizers. Long-term follow-up is needed to determine the effectiveness of these approaches in changing the natural history of the reproductive and metabolic outcomes without causing undue harm.

Key words: adolescent, polycystic ovary syndrome, therapeutics, insulin resistance, hyperandrogenism

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(06)00016-9

doi:10.1016/j.beem.2006.02.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Issue 2 , Pages 311-330, June 2006